Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,902 total articles
Nebius Group (NBIS) has been punished recently alongside other capital-intensive AI-infrastructure names, but the company’s large backlog, hyperscaler contracts and operational momentum argue for a tactically constructive trade. This idea lays out an entry at $100.58, a stop at $85.00 and a target at $140.00 for a long-term position (180 trading da…
Flowserve delivered the kind of operating leverage investors want to see: improving margins, meaningful free cash flow and order-book exposure to secular pump and valve markets. At a market cap near $11.2B, free cash flow of $435M and a 52-week high of $91.31, FLS offers a pragmatic long trade with defined risk and catalysts that can unlock upside …
Nebius Group has moved from pure-capex risk to a hybrid model where large hyperscaler contracts and customer-funded capacity materially change the balance of returns vs. risk. At $100.70 today and a $25.3B market cap, the stock is richly priced, but near-term catalysts and a sizable backlog give a path to justify upside. This trade idea outlines a …
Sprott Inc. reported a 146% earnings jump that validates my operational leverage thesis: fee-bearing exchange-listed products and balance-sheet lending are scaling faster than incremental costs. Combine that with recent trust-level initiatives, a higher quarterly dividend and positive commodity flows and you get a tradeable long with defined entry,…
Daiichi Sankyo has taken blows recently from regulatory and commercial setbacks, but the company’s diversified oncology and cardiovascular franchises, plus sizable biologics manufacturing capabilities, create a path to recovery. The sell-off looks disproportionate to the underlying value of the pipeline and manufacturing assets. This trade idea out…
Main Street Capital (MAIN) offers a high single-digit yield with a conservative balance sheet, reasonable valuation and an attractive entry after a recent pullback. For investors looking to complement bond holdings with equity income and modest capital upside, MAIN provides a trade-able setup with clear entry, stop and target.
Nebius is executing a blitz buildout of GPU-powered data centers and is benefiting from outsized hyperscaler spending. Revenue and ARR trajectories look explosive on paper, but high valuation and capital intensity make this a high-risk, high-reward swing trade. Entry, target, and stop are provided with a 45-trading-day horizon and explicit risks to…
Celsius has stabilized after the post-inventory shake-up with PepsiCo and shows signs of re-accelerating revenue and cash generation. The market is pricing strong growth into the stock (market cap ~$12.7B), but near-term technicals and improving fundamentals create a practical swing trade with defined risk.
Danaos (DAC) is trading near $108 but sits on a $4.3 billion contracted revenue backlog, reported adjusted EPS of $7.14 in Q4 2025 and holds $1.4 billion of liquidity. Management is returning capital aggressively while expanding contracted coverage and the fleet. Given a cheap multiple (PE ~4.1, PB ~0.54) and improving technical momentum, this trad…
Shinhan Financial (SHG) is trading near $69.93 with strong technical momentum, single-digit P/E and sub-1.0 P/B. With management emphasizing shareholder returns and a clear path to lift ROE, the stock looks actionable for a medium-term swing: enter at $69.93, stop $66.00, target $77.00. Key risks include elevated short activity, near-term overbough…
Amazon's recent pullback prices in a higher capex run that will depress free cash flow near term. But with AWS profitability, healthy ROE, a reasonable P/S multiple and technical oversold conditions, a long trade at current levels offers asymmetric upside. This idea lays out an entry, stop and target for a 180-trading-day trade and a clear checklis…
Pliant Therapeutics is a highly discounted clinical-stage biotech trading at roughly $76M market cap. The stock has been depressed by a paused BEACON-IPF trial and investor litigation, but an upcoming or recent lapse of a shareholder rights plan (poison pill) could allow strategic buyers to accumulate and force a revaluation. This trade idea buys t…
Booking Holdings is trading at a 52-week low after a steep pullback driven by AI disruption fears. The company's scale across Booking.com, Priceline, Agoda, KAYAK and OpenTable plus improving product initiatives (connected-trip, generative-chat integrations) keep its distribution moat intact. This trade targets a rebound into higher multiples with …
Baytex (BTE) looks cheap on book value and is showing constructive technicals, but the trade now hinges on whether recent strategic moves and infrastructure partnerships translate into better free cash flow and higher multiple. This trade idea lays out a mid-term long with entry at $3.74, a stop at $3.20 and a $4.40 target over 45 trading days, plu…
Sprouts Farmers Market (SFM) has re-rated sharply after a guidance cut and disappointing comps in 2025. With the stock trading near $71.75, the company shows attractive cash flow generation, low leverage, and a valuation that looks forgiving versus historic highs. This trade idea proposes a long with a defined entry, stop and target tied to a recov…
Dover (DOV) is a diversified industrial with predictable free cash flow, a modest balance sheet and exposure to several expanding end markets (fuel dispensers, flow meters, single-use pumps). Trading at roughly $231 today, the stock offers about a 3.6% free cash flow yield and a dividend while still sitting below where many investors pay for higher…
Electromed (ELMD) looks set for a short-term recovery from oversold technicals and steady cash generation. I recommend a tactical long targeting a fade toward prior moving averages, with a tight stop. However, valuation, a shallow float, and execution risk mean I would not hold past 10 trading days without clearer revenue/margin inflection.
Zscaler plunged amid a broad SaaS re-rating but its Zero Trust Exchange, recent SquareX acquisition, and strong free cash flow create a high-conviction long setup. Oversold technicals, rising short interest, and a valuation that still prices growth expectations below leader potential create an asymmetric trade for disciplined participants.
<p>Newmont (NEM) remains one of the safest ways to own gold exposure through an operating gold major: strong free cash flow, low leverage and attractive returns on capital. Today I downgrade the stock from Buy to Hold but recommend a tactical long-on-dip trade for disciplined traders. The thesis: own Newmont for balance-sheet strength and capital r…
Newmont offers asymmetric upside as a defensive commodity exposure with operational optionality. A disciplined entry at $37, stop at $30 and target at $48 gives a favourable risk/reward for a long-term (180 trading days) trade backed by macro and company-level catalysts.
PayPal looks like a cash machine that can no longer grow into its historic narrative. Weak execution on Branded Checkout, a surprise CEO exit, and multiple securities suits make the upside story fragile. At around $44, I recommend a mid-term short with tight risk controls: entry $44.00, stop $47.00, target $30.00 (45 trading days).
Johnson Controls (JCI) benefits from broad HVAC and energy-management tailwinds and a growing services mix that supports earnings resilience. Valuation is rich but justified by high ROE and recurring revenue; trade the stock long with a clear entry at $142.83, a stop at $137.00 and a target of $155.00 over the next 45 trading days.
Silvercorp is a complex mid-tier precious-metals miner that now offers a clear asymmetric trade: a market cap of ~$2.74B against a $522M after-tax NPV Condor PEA, steady Chinese silver-lead-zinc cashflow and an expanding project pipeline. We lay out an actionable long trade (entry $12.00, stop $9.50, target $30.00) for a long-term horizon (180 trad…
Toast is a mission-critical point-of-sale and restaurant management platform trading near its 52-week low. With $608M in free cash flow, $1.4B in cash, healthy liquidity ratios, and high customer integration, Toast looks better insulated from the latest 'SaaSpocalypse' headlines. The trade: initiate a long at $25.00, stop at $22.50, target $40.00 o…
Cullinan Therapeutics (CGEM) looks like a tactical long: clinical momentum around its CD19 T-cell engager CLN-978, positive data flow from zipalertinib, and a multi-hundred-million dollar cash position reduce near-term financing risk. We outline an actionable trade with entry at $14.00, stop at $11.00 and a $22.00 target over a 180 trading-day hori…
